Announcements Trials
Browse Landscape

Phase

Phase 2 17Phase 1 16Phase 1/2 7Phase EARLY_PHASE1 2Phase 3 2Phase NA 1Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 7Tumor-Agnostic 2Gastrointestinal 2Head & Neck 1CNS 1Breast 1

Conditions

Head and Neck Neoplasms 1

Interventions

Radiotherapy 26Standard of Care 25Surveys and Questionnaires 22Blood Specimen Collection 21Cisplatin 20Radiotherapy, Intensity-Modulated 19Magnetic Resonance Spectroscopy 19Biopsy 15Practice Guidelines as Topic 13Low-Level Light Therapy 13Exercise 10X-Rays 9Surgical Procedures, Operative 9Radiosurgery 9Interviews as Topic 9Therapeutics 8Magnetic Resonance Imaging 8Saline Solution 7Radiofrequency Ablation 7Radiation 7Fluorodeoxyglucose F18 7Transcutaneous Electric Nerve Stimulation 6Thyroidectomy 6Immunohistochemistry 6Educational Status 6Control Groups 6Chemoradiotherapy 6Cetuximab 6Biopsy, Fine-Needle 6Acupuncture Therapy 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Erlotinib Hydrochloride × Head & Neck × Clear all
NCT00144976 2015-03-27

Study of Biological Effect of Tarceva (OSI-774) for Patients Stricken by ENT Epidermoid Carcinoma

Institut Claudius Regaud

Phase NA Completed
43 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡